The Mexican consensus on the diagnosis and treatment of ulcerative colitis

被引：36

作者：

Yamamoto-Furusho, J. K. ^{[1
]}

Gutierrez-Grobe, Y. ^{[1
]}

Lopez-Gomez, J. G. ^{[2
]}

Bosques-Padilla, F. ^{[3
,4
]}

Rocha-Ramirez, J. L. ^{[5
]}

机构：

[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Gastroenterol, Clin Enfermedad Inflamatoria Intestinal, Vasco de Quiroga 15, Ciudad De Mexico 14080, Mexico

[2] ISSSTE, Ctr Med Nacl Noviembre 20, Clin Enfermedad Inflamatoria Intestinal, Ciudad De Mexico, Mexico

[3] UANL, Fac Med, Serv Gastroenterol, Gonzalez Monterrey, NL, Mexico

[4] Hosp Univ Dr Jose E, Gonzalez Monterrey, NL, Mexico

[5] Grp Acad & Invest Enfermedad Crohn & Colitis Ulce, Ciudad De Mexico, Mexico

来源：

REVISTA DE GASTROENTEROLOGIA DE MEXICO | 2018年 / 83卷 / 02期

关键词：

Ulcerative colitis; Diagnosis; Treatment; Epidemiology; Colectomy; Pouchitis;

D O I：

10.1016/j.rgmx.2017.08.006

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

The guidelines presented herein are an updated version of the recommendations published in 2007. Since then, there has been a rapid advance in the knowledge about the pathophysiology of ulcerative colitis and its therapeutic options. New drugs have been approved, novel targeted therapies have emerged, and new strategies have been developed to improve the previously available approaches to the disease. The aim of the present consensus is to promote the current knowledge of and Mexican perspective on the epidemiology, diagnosis, and medical and surgical treatment of chronic idiopathic ulcerative colitis. The final vote on the statements and their ultimate modifications were carried out at the consensus working group meeting. Evidence was evaluated through the GRADE classification. (C) 2018 Asociacion Mexicana de Gastroenterologia. Published by Masson Doyma Mexico S.A.

引用

页码：144 / 167

页数：24

共 183 条

[1] Predictors for acute and chronic pouchitis following restorative proctocolectomy for ulcerative colitis [J].

Abdelrazeq, A. S. ;

Kandiyil, N. ;

Botterill, I. D. ;

Lund, J. N. ;

Reynolds, J. R. ;

Holdsworth, P. J. ;

Leveson, S. H. .

COLORECTAL DISEASE, 2008, 10 (08) :805-813

[2]

ADSON MA, 1972, ARCH SURG-CHICAGO, V104, P424

[3] Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease [J].

Afif, Waqqas ;

Loftus, Edward V., Jr. ;

Faubion, William A. ;

Kane, Sunanda V. ;

Bruining, David H. ;

Hanson, Karen A. ;

Sandborn, William J. .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (05) :1133-1139

[4] Racial and Ethnic Minorities with Inflammatory Bowel Disease in the United States: A Systematic Review of Disease Characteristics and Differences [J].

Afzali, Anita ;

Cross, Raymond K. .

INFLAMMATORY BOWEL DISEASES, 2016, 22 (08) :2023-2040

[5]

Ali U Ahmed, 2009, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD006267.PUB

[6] Epidemiology and risk factors for IBD [J].

Ananthakrishnan, Ashwin N. .

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2015, 12 (04) :205-217

[7] Aspirin, Nonsteroidal Anti-inflammatory Drug Use, and Risk for Crohn Disease and Ulcerative Colitis A Cohort Study [J].

Ananthakrishnan, Ashwin N. ;

Higuchi, Leslie M. ;

Huang, Edward S. ;

Khalili, Hamed ;

Richter, James M. ;

Fuchs, Charles S. ;

Chan, Andrew T. .

ANNALS OF INTERNAL MEDICINE, 2012, 156 (05) :350-U170

[8] Surgery in Ulcerative Colitis: Indication and Timing [J].

Andersson, Peter ;

Soderholm, Johan D. .

DIGESTIVE DISEASES, 2009, 27 (03) :335-340

[9] Appendectomy and protection against ulcerative colitis. [J].

Andersson, RE ;

Olaison, G ;

Tysk, C ;

Ekbom, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) :808-814

[10] Update on medical and surgical options for patients with acute severe ulcerative colitis: what is new? [J].

Andrew, Rachel E. ;

Messaris, Evangelos .

WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2016, 8 (09) :598-605

← 1 2 3 4 5 6 7 8 9 10 →